<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01752439</url>
  </required_header>
  <id_info>
    <org_study_id>tDCSCMMOH1</org_study_id>
    <nct_id>NCT01752439</nct_id>
  </id_info>
  <brief_title>Effects of Transcranial Direct Current Stimulation in Refractory Chronic Migraine and Medication-overuse Headache</brief_title>
  <official_title>Randomized Double-Blind Sham-Controlled Study of the Effects of Transcranial Direct Current Stimulation in Refractory Chronic Migraine and Medication-overuse Headache Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr Armando Perrotta, MD, PhD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mediterranean Neurological Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the efficacy of the transcranial direct current
      stimulation of the primary motor cortex (M1) in patients affected by refractory chronic
      migraine (coded as 1.5.1 in the international headache classification 2nd edition, 2004) and
      medication-overuse headache (coded as 8.1) with migraine as primary headache.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in headache days per months</measure>
    <time_frame>at 30, 60 and 90 days after the treatment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in drugs intake per months</measure>
    <time_frame>at 30, 60 and 90 days after treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in mean pain intensity score per months</measure>
    <time_frame>at 30, 60 and 90 days after treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Chronic Migraine</condition>
  <condition>Medication Overuse Headache</condition>
  <arm_group>
    <arm_group_label>Anodal transcranial direct current stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Anodal transcranial direct current stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham transcranial direct current stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham transcranial direct current stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Anodal transcranial direct current stimulation</intervention_name>
    <arm_group_label>Anodal transcranial direct current stimulation</arm_group_label>
    <other_name>Transcranial direct current stimulator HDCstim, Newronika s.r.l., Milan, Italy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham transcranial direct current stimulation</intervention_name>
    <arm_group_label>Sham transcranial direct current stimulation</arm_group_label>
    <other_name>Transcranial direct current stimulator HDCstim, Newronika s.r.l., Milan, Italy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic MIgraine or Medication Overuse Headache according to the diagnostic criteria
             set out in the 2nd edition of the International Classification of Headache Disorders
             refractory to treatment according to the Refractory Headache Special Interest Section
             of the American Headache Society (Schulman et al., 2008)

        Exclusion Criteria:

          -  Other primary or secondary headaches.

          -  Any serious systemic or neurological disease or psychiatric disorder.

          -  Pregnancy or breastfeeding

          -  Previous or current use of other or similar devices for pain control

          -  Heart conduction and rhythm disorders

          -  Cranial surgery

          -  Other pain conditions, accordingly with current guidelines
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 11, 2012</study_first_submitted>
  <study_first_submitted_qc>December 14, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 19, 2012</study_first_posted>
  <last_update_submitted>December 14, 2012</last_update_submitted>
  <last_update_submitted_qc>December 14, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 19, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Mediterranean Neurological Institute</investigator_affiliation>
    <investigator_full_name>Dr Armando Perrotta, MD, PhD</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Chronic Migraine</keyword>
  <keyword>Medication Overuse Headache</keyword>
  <keyword>Refractory</keyword>
  <keyword>transcranial direct current stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Headache</mesh_term>
    <mesh_term>Headache Disorders, Secondary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

